Amphastar Pharmaceuticals, Inc. (AMPH)
17.83
+0.63
(+3.66%)
USD |
NASDAQ |
May 19, 16:00
17.80
-0.03
(-0.17%)
After-Hours: 17:44
Amphastar Pharmaceuticals Cash from Investing (Quarterly) : -16.73M for March 31, 2026
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Supernus Pharmaceuticals, Inc. | -19.22M |
| Amneal Pharmaceuticals, Inc. | -21.71M |
| Corcept Therapeutics, Inc. | 4.542M |
| Assertio Holdings, Inc. | 15.11M |
| Johnson & Johnson | -1.04B |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 47.84M |
| Cash from Financing (Quarterly) | -30.21M |
| Free Cash Flow | 132.94M |
| Free Cash Flow Per Share (Quarterly) | 0.8251 |
| Free Cash Flow to Equity (Quarterly) | 7.957M |
| Free Cash Flow to Firm (Quarterly) | 42.52M |
| Free Cash Flow Yield | 15.74% |